Injecto Group A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  0.0% 5.2% 6.1% 3.6% 2.6%  
Credit score (0-100)  0 41 38 51 62  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  61.2 0.0 0.0 0.0 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Net sales  0 224 136 100 343  
Gross profit  0.0 -1,479 -3,026 -3,185 -3,257  
EBITDA  0.0 -3,042 -5,088 -4,408 -4,035  
EBIT  0.0 -5,651 -7,848 -7,290 -7,083  
Pre-tax profit (PTP)  0.0 -10,124.6 -13,943.3 -7,136.8 -6,547.4  
Net earnings  0.0 -10,124.6 -15,234.0 -7,136.8 -6,547.4  
Pre-tax profit without non-rec. items  0.0 -10,125 -13,943 -7,137 -6,547  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Tangible assets total  0.0 185 128 427 141  
Shareholders equity total  0.0 25,314 38,458 55,466 54,970  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 45,864 40,083 57,133 55,904  

Net Debt  -1,209 -2,067 -802 -3,817 -1,745  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Net sales  0 224 136 100 343  
Net sales growth  -100.0% 0.0% -39.3% -26.6% 243.3%  
Gross profit  0.0 -1,479 -3,026 -3,185 -3,257  
Gross profit growth  0.0% 0.0% -104.6% -5.3% -2.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 45,864 40,083 57,133 55,904  
Balance sheet change%  -100.0% 0.0% -12.6% 42.5% -2.2%  
Added value  0.0 -3,041.9 -5,088.0 -4,530.1 -4,035.2  
Added value %  0.0% -1,356.4% -3,735.9% -4,530.1% -1,175.5%  
Investments  -5,010 37,085 -42,327 -2,582 -2,634  

Net sales trend  -1.0 0.0 -1.0 -2.0 1.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
EBITDA %  0.0% -1,356.4% -3,735.9% -4,408.4% -1,175.5%  
EBIT %  0.0% -2,520.0% -5,762.5% -7,290.1% -2,063.5%  
EBIT to gross profit (%)  0.0% 382.2% 259.3% 228.9% 217.5%  
Net Earnings %  0.0% -4,514.6% -11,185.8% -7,136.8% -1,907.4%  
Profit before depreciation and extraordinary items %  0.0% -3,351.0% -9,159.2% -4,255.1% -1,019.5%  
Pre tax profit less extraordinaries %  0.0% -4,514.6% -10,238.0% -7,136.8% -1,907.4%  
ROA %  0.0% -11.9% -17.5% -13.7% -11.6%  
ROI %  0.0% -12.2% -18.1% -14.1% -11.8%  
ROE %  0.0% -40.0% -47.8% -15.2% -11.9%  

Solidity 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Equity ratio %  0.0% 55.2% 95.9% 97.1% 98.3%  
Relative indebtedness %  0.0% 9,163.3% 1,192.7% 1,667.5% 271.9%  
Relative net indebtedness %  0.0% 8,241.8% 603.9% -2,149.9% -236.5%  
Net int. bear. debt to EBITDA, %  0.0% 67.9% 15.8% 86.6% 43.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Quick Ratio  0.0 4.2 1.1 3.3 5.2  
Current Ratio  0.0 4.2 1.1 3.3 5.2  
Cash and cash equivalent  1,209.1 2,066.5 802.0 3,817.4 1,745.3  

Capital use efficiency 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Trade debtors turnover (days)  0.0 1,155.7 2,271.8 38.6 199.0  
Trade creditors turnover (days)  0.0 60.5 91.5 54.2 72.8  
Current assets / Net sales %  0.0% 2,165.5% 1,219.6% 5,048.0% 1,423.5%  
Net working capital  0.0 3,710.2 186.6 3,510.7 3,952.8  
Net working capital %  0.0% 1,654.4% 137.0% 3,510.7% 1,151.5%  

Employee efficiency 
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0